The bill amends Minnesota Statutes 2025 Supplement, section 256B.0625, subdivision 13d, to prohibit medical assistance coverage for prescription drugs that are solely intended for weight loss. This change is part of a broader effort to establish a drug formulary that excludes certain categories of drugs, including those without federal funding, over-the-counter drugs (with some exceptions), and drugs lacking established medical value. Specifically, the new language adds a provision that explicitly states that drugs or active pharmaceutical ingredients used only for weight loss will not be included in the formulary.

Additionally, the bill outlines the responsibilities of the commissioner of human services regarding the drug formulary, including notification requirements for changes and annual reporting on the effects of these changes on enrollees. The effective date for this section is set for January 1, 2027, or upon federal approval, whichever occurs later. This legislative action aims to ensure that medical assistance funds are allocated to drugs with established medical benefits, thereby enhancing the overall efficacy of the drug formulary.